Allopurinol in Renal Ischemia
Authors:
- Anna Carabén-RedañoACAnna Carabén-Redaño
- Alicia Aliena-ValeroAAAlicia Aliena-Valero
- Dolores CejalvoDCDolores Cejalvo
- Alexander H. ToledoATAlexander H. Toledo
- Miguel Flores-BellverMFMiguel Flores-Bellver
- Natalia Martínez-GilNMNatalia Martínez-Gil
- Luis H. Toledo-PereyraLTLuis H. Toledo-Pereyra
- José Miguel Lloris CarsíJCJosé Miguel Lloris Carsí
- 19 December 2013
- journal article
- review article
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 27 (5) , 304-316
Abstract
Allopurinol is a xanthine oxidase inhibitor and antioxidant free radical scavenger which facilitates the protection of ischemic organs in part via this mechanism of action. The accumulation of free radicals during ischemia and reperfusion is in great manner overcome by inhibitors of xanthine oxidase and by the development of endogenous antioxidants. The ischemic lesion generates a well-established inflammatory response with the subsequent production of inflammatory molecules characteristically present at the first stages of the injury. Inflammatory cytokines, chemokines, adhesion molecules, and other cellular and molecular compounds are consequently produced as the lesion sets in. Under these conditions, allopurinol diminishes the effect of inflammatory mediators during the ischemic inflammatory response. This study reviews the literature associated with allopurinol and renal ischemia making special emphasis on the best dose and time of administration of allopurinol regarding its protective effect. It also defines the most accepted mechanism of protection on ischemichally damaged kidneys.Keywords
This publication has 92 references indexed in Scilit:
- First Prize: Isoprostane: Quantitation of Renal Ischemia and Reperfusion Injury After Renal Artery Clamping in an Animal ModelJournal of Endourology, 2012
- Distinct Macrophage Phenotypes Contribute to Kidney Injury and RepairJournal of the American Society of Nephrology, 2011
- TLR4 activation mediates kidney ischemia/reperfusion injuryJournal of Clinical Investigation, 2007
- Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathwaysApoptosis, 2006
- Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injuryJournal of Pediatric Surgery, 2003
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- Clinical Pharmacokinetics of AllopurinolClinical Pharmacokinetics, 1986
- Responses of the ischemic myocardium to allopurinolAmerican Heart Journal, 1971
- STUDIES ON ANALOGS OF PURINES AND PYRIMIDINESAnnals of the New York Academy of Sciences, 1950
- The Ultraviolet Absorption Spectra of Thiouracils1Journal of the American Chemical Society, 1946